Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast-track versus standard timing of thyroidectomy and radioiodine ablation in differentiated thyroid cancer
NL-OMON21104Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2013
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Randomised, open-label trial of thyrotropin alfa and iodine-131 in well-differentiated thyroid cancer (WDTC) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Days of sick leave reported from time of surgery. Started Nov 2013; status: active, not recruiting.
02
Drugs
thyrotropin alfaiodine-131
03
Conditions
well-differentiated thyroid cancer (WDTC)
Beyond the preview
Go deeper on NL-OMON21104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21104.